EUVIMEDEUVIMED entdecken
Fallbericht

Effects of Antiresorptive Treatment on Bone Mineral Density and Bone Turnover Markers in a Child With Steroid‐Resistant Nephrotic Syndrome: A Case Report

Jun Aoyagi iD, Takahiro Kanai, Takane Ito, Masanori Kurosaki iD, Tomomi Maru, Marika Ishii, Kazuya Tanimoto, Toshihiro Tajima

Nephrology · 2026-07 · 31 (7)

DOI: 10.1111/nep.70245 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Nephrology, online erschienen am 06.07.2026. Verfasst von Jun Aoyagi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Jichi Medical University, Shimotsuke, Japan. Hauptthemen laut MEDLINE: Nephrotic Syndrome, Bone Density, Glucocorticoids, Bone Density Conservation Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glucocorticoid‐induced osteoporosis (GIOP) is a significant complication of prolonged glucocorticoid treatment in paediatric nephrotic syndrome, but the optimal treatment strategy remains unclear. We report the case of a 17‐year‐old boy with steroid‐resistant nephrotic syndrome due to focal segmental glomerulosclerosis who developed progressive bone fragility during high‐dose glucocorticoid treatment. Four months after initiation of glucocorticoids, his lumbar bone mineral density (BMD) decreased 9.2%, serum alkaline phosphatase (S‐ALP) decreased 22% and serum tartrate‐resistant acid phosphatase‐5b (S‐TRACP‐5b) increased 47% compared with baseline, indicating compromised bone strength. Oral alendronate (35 mg/week) was initiated to prevent progression of GIOP. One month after antiresorptive treatment, S‐TRACP‐5b decreased 87% from the level measured at 4 months. BMD and S‐ALP initially continued to decline slightly until 7 months but subsequently demonstrated sustained recovery. S‐TRACP‐5b levels were lower than baseline levels to a greater extent than the S‐ALP levels between 5 and 28M, corresponding to progressive improvement in the BMD. No fragility fractures or adverse events occurred, and remission of nephrotic syndrome was maintained. This case suggests that alendronate rapidly suppresses bone resorption, promotes a bone formation‐dominant state in conjunction with glucocorticoid tapering and may prevent bone fragility in paediatric GIOP. A ≥ 34% increase in S‐TRACP‐5b accompanied by a ≥ 22% decrease in S‐ALP from baseline may indicate the appropriate timing for initiating antiresorptive treatment. Further investigations are warranted to establish evidence‐based management strategies for paediatric GIOP.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Nephrotic SyndromeBone DensityGlucocorticoidsBone Density Conservation AgentsAlendronateBone RemodelingOsteoporosisHumansMaleAdolescentBiomarkersTartrate-Resistant Acid PhosphataseTreatment OutcomeDrug ResistanceAlkaline PhosphataseTime Factors

Stichwörter der Autor:innen

alendronatebone mineral densitybone turnover markerchildglucocorticoid‐induced osteoporosisnephrotic syndrome

Substanzen

GlucocorticoidsBone Density Conservation AgentsAlendronateBiomarkersTartrate-Resistant Acid PhosphataseACP5 protein, humanAlkaline Phosphatase

Autor:innen und Institutionen

  • Department of Pediatrics, Jichi Medical University, Shimotsuke, Japan.

ORCID-Profile: Jun Aoyagi, Masanori Kurosaki

Zitieren

APA

Aoyagi, J., Kanai, T., Ito, T., Kurosaki, M., Maru, T., Ishii, M., Tanimoto, K., & Tajima, T. (2026). Effects of Antiresorptive Treatment on Bone Mineral Density and Bone Turnover Markers in a Child With Steroid‐Resistant Nephrotic Syndrome: A Case Report. Nephrology, 31(7). https://doi.org/10.1111/nep.70245

Vancouver

Aoyagi J, Kanai T, Ito T, Kurosaki M, Maru T, Ishii M, et al. Effects of Antiresorptive Treatment on Bone Mineral Density and Bone Turnover Markers in a Child With Steroid‐Resistant Nephrotic Syndrome: A Case Report. Nephrology. 2026;31(7). doi:10.1111/nep.70245

BibTeX
@article{Aoyagi2026,
  author = {Aoyagi, Jun and Kanai, Takahiro and Ito, Takane and Kurosaki, Masanori and Maru, Tomomi and Ishii, Marika and Tanimoto, Kazuya and Tajima, Toshihiro},
  title = {Effects of Antiresorptive Treatment on Bone Mineral Density and Bone Turnover Markers in a Child With Steroid‐Resistant Nephrotic Syndrome: A Case Report},
  journal = {Nephrology},
  year = {2026},
  volume = {31},
  number = {7},
  doi = {10.1111/nep.70245}
}
Kostenlos starten →